C4 Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 03:30PM GMT
Eric William Joseph - JPMorgan Chase & Co, Research Division - VP & Senior Analyst

Okay. Good morning, and welcome again to the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst for the firm. Our next presenting company is C4 Therapeutics, and to talk to us a little bit about the company, it's my pleasure to introduce CEO, Andrew Hirsch. There will be a Q&A session after the presentation. Feel free to submit questions by clicking the Ask A Question icon.

With that, Andrew, thanks so much for sharing some of your time with us this morning.

Andrew J. Hirsch - C4 Therapeutics, Inc. - CEO, President & Director

Great. Thanks, Eric. Good morning, everyone, and thanks for joining our presentation. Before I begin, I'd like to thank JPMorgan for inviting us to participate in the conference, and I'm pleased to share an update on C4 Therapeutics today.

You should all have access to the slides, that I'll indicate which slide number I'm on as I progress through the presentation. I'll be making forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot